

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | carnitine shuttle (GO:0006853) | 5.93067251 |
| 2 | tricarboxylic acid cycle (GO:0006099) | 5.75310406 |
| 3 | fatty acid transmembrane transport (GO:1902001) | 5.74749354 |
| 4 | lysine metabolic process (GO:0006553) | 5.58036949 |
| 5 | lysine catabolic process (GO:0006554) | 5.58036949 |
| 6 | COPI coating of Golgi vesicle (GO:0048205) | 5.13393681 |
| 7 | Golgi transport vesicle coating (GO:0048200) | 5.13393681 |
| 8 | * fatty acid beta-oxidation (GO:0006635) | 5.11601163 |
| 9 | 2-oxoglutarate metabolic process (GO:0006103) | 5.04877651 |
| 10 | regulation of sequestering of triglyceride (GO:0010889) | 5.04013666 |
| 11 | sarcomere organization (GO:0045214) | 4.78178239 |
| 12 | carnitine transmembrane transport (GO:1902603) | 4.66558955 |
| 13 | aspartate family amino acid catabolic process (GO:0009068) | 4.59525780 |
| 14 | regulation of fatty acid oxidation (GO:0046320) | 4.58758987 |
| 15 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.52345290 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 4.52183040 |
| 17 | * fatty acid oxidation (GO:0019395) | 4.51089906 |
| 18 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.50462745 |
| 19 | cardiac myofibril assembly (GO:0055003) | 4.49241579 |
| 20 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.47161167 |
| 21 | amino-acid betaine transport (GO:0015838) | 4.46297653 |
| 22 | carnitine transport (GO:0015879) | 4.46297653 |
| 23 | * fatty acid catabolic process (GO:0009062) | 4.44608978 |
| 24 | acetyl-CoA metabolic process (GO:0006084) | 4.43819079 |
| 25 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.43675227 |
| 26 | * lipid oxidation (GO:0034440) | 4.42151324 |
| 27 | glyoxylate metabolic process (GO:0046487) | 4.34981119 |
| 28 | regulation of triglyceride catabolic process (GO:0010896) | 4.33590534 |
| 29 | amino-acid betaine metabolic process (GO:0006577) | 4.27591207 |
| 30 | carnitine metabolic process (GO:0009437) | 4.26156967 |
| 31 | positive regulation of fatty acid oxidation (GO:0046321) | 4.22328670 |
| 32 | NADH metabolic process (GO:0006734) | 4.18508483 |
| 33 | L-phenylalanine metabolic process (GO:0006558) | 4.18485868 |
| 34 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.18485868 |
| 35 | L-phenylalanine catabolic process (GO:0006559) | 4.15819815 |
| 36 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.15819815 |
| 37 | short-chain fatty acid metabolic process (GO:0046459) | 4.14937013 |
| 38 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.14274935 |
| 39 | cellular ketone body metabolic process (GO:0046950) | 4.13140686 |
| 40 | valine metabolic process (GO:0006573) | 4.12601704 |
| 41 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.05502804 |
| 42 | tricarboxylic acid metabolic process (GO:0072350) | 4.05087168 |
| 43 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.04555791 |
| 44 | branched-chain amino acid catabolic process (GO:0009083) | 4.03813306 |
| 45 | biotin metabolic process (GO:0006768) | 4.01189942 |
| 46 | * monocarboxylic acid catabolic process (GO:0072329) | 3.98220834 |
| 47 | low-density lipoprotein particle clearance (GO:0034383) | 3.94792569 |
| 48 | myofibril assembly (GO:0030239) | 3.94110421 |
| 49 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.93554443 |
| 50 | kynurenine metabolic process (GO:0070189) | 3.92420392 |
| 51 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.81702622 |
| 52 | branched-chain amino acid metabolic process (GO:0009081) | 3.76805831 |
| 53 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.75722438 |
| 54 | pentose-phosphate shunt (GO:0006098) | 3.75326257 |
| 55 | oxaloacetate metabolic process (GO:0006107) | 3.66412116 |
| 56 | proline biosynthetic process (GO:0006561) | 3.66060082 |
| 57 | succinate metabolic process (GO:0006105) | 3.63053002 |
| 58 | ketone body metabolic process (GO:1902224) | 3.59808533 |
| 59 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.59639459 |
| 60 | regulation of cofactor metabolic process (GO:0051193) | 3.59278823 |
| 61 | regulation of coenzyme metabolic process (GO:0051196) | 3.59278823 |
| 62 | aromatic amino acid family catabolic process (GO:0009074) | 3.58920066 |
| 63 | phospholipid homeostasis (GO:0055091) | 3.58865849 |
| 64 | ethanol oxidation (GO:0006069) | 3.55223704 |
| 65 | NADPH regeneration (GO:0006740) | 3.54684733 |
| 66 | positive regulation of lipid catabolic process (GO:0050996) | 3.53989376 |
| 67 | quaternary ammonium group transport (GO:0015697) | 3.52588471 |
| 68 | actin-myosin filament sliding (GO:0033275) | 3.49208207 |
| 69 | muscle filament sliding (GO:0030049) | 3.49208207 |
| 70 | sulfur amino acid catabolic process (GO:0000098) | 3.48360395 |
| 71 | cardiac muscle contraction (GO:0060048) | 3.46967537 |
| 72 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.43950656 |
| 73 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.42975458 |
| 74 | pinocytosis (GO:0006907) | 3.42418008 |
| 75 | COPII vesicle coating (GO:0048208) | 3.41728816 |
| 76 | nitrogen cycle metabolic process (GO:0071941) | 3.38901795 |
| 77 | creatine metabolic process (GO:0006600) | 3.38887101 |
| 78 | cardiac muscle cell development (GO:0055013) | 3.35579638 |
| 79 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.32613267 |
| 80 | glycosphingolipid catabolic process (GO:0046479) | 3.32127210 |
| 81 | angiotensin maturation (GO:0002003) | 3.31794944 |
| 82 | plasma lipoprotein particle clearance (GO:0034381) | 3.31475214 |
| 83 | fatty acid homeostasis (GO:0055089) | 3.28519804 |
| 84 | bile acid biosynthetic process (GO:0006699) | 3.27757172 |
| 85 | homocysteine metabolic process (GO:0050667) | 3.27615267 |
| 86 | triglyceride homeostasis (GO:0070328) | 3.25907126 |
| 87 | acylglycerol homeostasis (GO:0055090) | 3.25907126 |
| 88 | negative regulation of fatty acid metabolic process (GO:0045922) | 3.25733579 |
| 89 | fructose metabolic process (GO:0006000) | 3.25731977 |
| 90 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.25239809 |
| 91 | * organic acid catabolic process (GO:0016054) | 3.25075471 |
| 92 | * carboxylic acid catabolic process (GO:0046395) | 3.25075471 |
| 93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.22128168 |
| 94 | alpha-amino acid catabolic process (GO:1901606) | 3.21738574 |
| 95 | cysteine metabolic process (GO:0006534) | 3.21113668 |
| 96 | regulation of cholesterol metabolic process (GO:0090181) | 3.19851920 |
| 97 | serine family amino acid catabolic process (GO:0009071) | 3.18845519 |
| 98 | intracellular lipid transport (GO:0032365) | 3.17994658 |
| 99 | complement activation, alternative pathway (GO:0006957) | 3.16870093 |
| 100 | indole-containing compound catabolic process (GO:0042436) | 3.15562387 |
| 101 | indolalkylamine catabolic process (GO:0046218) | 3.15562387 |
| 102 | tryptophan catabolic process (GO:0006569) | 3.15562387 |
| 103 | protein-lipid complex assembly (GO:0065005) | 3.15300749 |
| 104 | heart trabecula formation (GO:0060347) | 3.13750858 |
| 105 | cardiac cell development (GO:0055006) | 3.13590488 |
| 106 | urea metabolic process (GO:0019627) | 3.12961692 |
| 107 | urea cycle (GO:0000050) | 3.12961692 |
| 108 | negative regulation of fibrinolysis (GO:0051918) | 3.12000053 |
| 109 | regulation of skeletal muscle contraction (GO:0014819) | 3.11951997 |
| 110 | regulation of sulfur metabolic process (GO:0042762) | 3.11475510 |
| 111 | plasma lipoprotein particle assembly (GO:0034377) | 3.11193814 |
| 112 | regulation of cholesterol esterification (GO:0010872) | 3.10654593 |
| 113 | glycolipid catabolic process (GO:0019377) | 3.10433125 |
| 114 | protein carboxylation (GO:0018214) | 3.08814684 |
| 115 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.08814684 |
| 116 | cellular amino acid catabolic process (GO:0009063) | 3.08302088 |
| 117 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.08245672 |
| 118 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.08034336 |
| 119 | glucose catabolic process (GO:0006007) | 3.04640687 |
| 120 | plasma membrane repair (GO:0001778) | 3.04496689 |
| 121 | glucose 6-phosphate metabolic process (GO:0051156) | 3.03027638 |
| 122 | regulation of cholesterol homeostasis (GO:2000188) | 3.02005849 |
| 123 | gluconeogenesis (GO:0006094) | 2.99055947 |
| 124 | response to thyroid hormone (GO:0097066) | 2.97652462 |
| 125 | regulation of cholesterol storage (GO:0010885) | 2.94486442 |
| 126 | formation of translation preinitiation complex (GO:0001731) | 2.93079363 |
| 127 | monosaccharide biosynthetic process (GO:0046364) | 2.91897106 |
| 128 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.90874210 |
| 129 | oligosaccharide catabolic process (GO:0009313) | 2.85287189 |
| 130 | protoporphyrinogen IX metabolic process (GO:0046501) | 2.82774338 |
| 131 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.80680163 |
| 132 | hexose biosynthetic process (GO:0019319) | 2.79737939 |
| 133 | phospholipid efflux (GO:0033700) | 2.71839617 |
| 134 | intestinal absorption (GO:0050892) | 2.69981655 |
| 135 | triglyceride catabolic process (GO:0019433) | 2.69057952 |
| 136 | proline metabolic process (GO:0006560) | 2.67145528 |
| 137 | barbed-end actin filament capping (GO:0051016) | 2.66306785 |
| 138 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.66017921 |
| 139 | vesicle coating (GO:0006901) | 2.62579380 |
| 140 | actin-mediated cell contraction (GO:0070252) | 2.58687477 |
| 141 | epoxygenase P450 pathway (GO:0019373) | 2.55193895 |
| 142 | regulation of protein activation cascade (GO:2000257) | 2.54352150 |
| 143 | cellular hyperosmotic response (GO:0071474) | 2.53981496 |
| 144 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.52190928 |
| 145 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.52190928 |
| 146 | protein-lipid complex subunit organization (GO:0071825) | 2.51983427 |
| 147 | peptide catabolic process (GO:0043171) | 2.51374854 |
| 148 | regulation of complement activation (GO:0030449) | 2.51372090 |
| 149 | plasma lipoprotein particle remodeling (GO:0034369) | 2.50619119 |
| 150 | protein-lipid complex remodeling (GO:0034368) | 2.50619119 |
| 151 | macromolecular complex remodeling (GO:0034367) | 2.50619119 |
| 152 | regulation of translational fidelity (GO:0006450) | 2.50356605 |
| 153 | neutral lipid catabolic process (GO:0046461) | 2.49615680 |
| 154 | acylglycerol catabolic process (GO:0046464) | 2.49615680 |
| 155 | low-density lipoprotein particle remodeling (GO:0034374) | 2.48839649 |
| 156 | ceramide catabolic process (GO:0046514) | 2.48197178 |
| 157 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.46902028 |
| 158 | thioester biosynthetic process (GO:0035384) | 2.46309881 |
| 159 | acyl-CoA biosynthetic process (GO:0071616) | 2.46309881 |
| 160 | plasma lipoprotein particle organization (GO:0071827) | 2.45778730 |
| 161 | nuclear pore complex assembly (GO:0051292) | 2.45660406 |
| 162 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.44282064 |
| 163 | desmosome organization (GO:0002934) | 2.42831625 |
| 164 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.41115010 |
| 165 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.40665422 |
| 166 | oxidative phosphorylation (GO:0006119) | 2.40438450 |
| 167 | linoleic acid metabolic process (GO:0043651) | 2.40239639 |
| 168 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.38948745 |
| 169 | glycolytic process (GO:0006096) | 2.38768780 |
| 170 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.38521451 |
| 171 | triglyceride metabolic process (GO:0006641) | 2.36521333 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 8.61869356 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 8.54731764 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.91190263 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.45736865 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.86480670 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.43913434 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.84193973 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.49618211 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.49046198 |
| 10 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.00648669 |
| 11 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.87775821 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.79404462 |
| 13 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.74995380 |
| 14 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.53431595 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.43290046 |
| 16 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.40758189 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.40382918 |
| 18 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.30490814 |
| 19 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.30490814 |
| 20 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.09606044 |
| 21 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.92186921 |
| 22 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.74857140 |
| 23 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.74315924 |
| 24 | GATA1_22025678_ChIP-Seq_K562_Human | 1.73719816 |
| 25 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.72095165 |
| 26 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.69493630 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.69214464 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64305327 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.64141348 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.63564598 |
| 31 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.59680157 |
| 32 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.56455950 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55384648 |
| 34 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.55122734 |
| 35 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.53070991 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.51526387 |
| 37 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.50116808 |
| 38 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.45508548 |
| 39 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.42330805 |
| 40 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.38480627 |
| 41 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.38070568 |
| 42 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.37476987 |
| 43 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.37012991 |
| 44 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.36278482 |
| 45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35716114 |
| 46 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.34687848 |
| 47 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.34393909 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.33882557 |
| 49 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.33832049 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.33047182 |
| 51 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29847341 |
| 52 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.28880832 |
| 53 | * ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.25022486 |
| 54 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.24051575 |
| 55 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.23143897 |
| 56 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.22891080 |
| 57 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.21702430 |
| 58 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18988260 |
| 59 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.18347898 |
| 60 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.17773638 |
| 61 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.16422294 |
| 62 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.15894093 |
| 63 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15021491 |
| 64 | * MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.15010587 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.14952589 |
| 66 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14135143 |
| 67 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13961984 |
| 68 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.13801539 |
| 69 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.13677117 |
| 70 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.12286204 |
| 71 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.10855913 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.10114169 |
| 73 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.10089084 |
| 74 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.09882691 |
| 75 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.09255777 |
| 76 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08164073 |
| 77 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.07580710 |
| 78 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.06505678 |
| 79 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.06374031 |
| 80 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06143285 |
| 81 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06080494 |
| 82 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.05666868 |
| 83 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.03767417 |
| 84 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.03200470 |
| 85 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.03059694 |
| 86 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.02220320 |
| 87 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.01291607 |
| 88 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.00790491 |
| 89 | * CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.00647478 |
| 90 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.00083647 |
| 91 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.99382576 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.99129792 |
| 93 | MAF_26560356_Chip-Seq_TH1_Human | 0.98928567 |
| 94 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.97755845 |
| 95 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.97551645 |
| 96 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.97384531 |
| 97 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97262794 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.97109360 |
| 99 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97078472 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.95812183 |
| 101 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.95424493 |
| 102 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.94147548 |
| 103 | SPI1_23127762_ChIP-Seq_K562_Human | 0.93871551 |
| 104 | ATF3_27146783_Chip-Seq_COLON_Human | 0.93841133 |
| 105 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.93416535 |
| 106 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93399249 |
| 107 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.93037166 |
| 108 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.92675258 |
| 109 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88220639 |
| 110 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.85809872 |
| 111 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.85631447 |
| 112 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.84566827 |
| 113 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.84444343 |
| 114 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82907969 |
| 115 | GATA2_19941826_ChIP-Seq_K562_Human | 0.82297754 |
| 116 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.81597225 |
| 117 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.79147112 |
| 118 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.79104721 |
| 119 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.78236979 |
| 120 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.77537329 |
| 121 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.76452322 |
| 122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.76066074 |
| 123 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75635200 |
| 124 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.75371760 |
| 125 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.75341974 |
| 126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.75206453 |
| 127 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75123059 |
| 128 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.75100930 |
| 129 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.74317080 |
| 130 | P68_20966046_ChIP-Seq_HELA_Human | 0.73464904 |
| 131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.72246220 |
| 132 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.71192068 |
| 133 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.70458513 |
| 134 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.70200303 |
| 135 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68544705 |
| 136 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.68422140 |
| 137 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.67821265 |
| 138 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.66854617 |
| 139 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.66804777 |
| 140 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.66792771 |
| 141 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.66139396 |
| 142 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.65728212 |
| 143 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.64755408 |
| 144 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.64623654 |
| 145 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.64079978 |
| 146 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.64060353 |
| 147 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.63881327 |
| 148 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.63833511 |
| 149 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.63570324 |
| 150 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.62793733 |
| 151 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.62602469 |
| 152 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.62538713 |
| 153 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.61014845 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.01385964 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.20396439 |
| 3 | MP0005360_urolithiasis | 4.01998149 |
| 4 | MP0003646_muscle_fatigue | 3.88240115 |
| 5 | MP0004084_abnormal_cardiac_muscle | 3.74807089 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.60055307 |
| 7 | MP0005365_abnormal_bile_salt | 3.39447545 |
| 8 | MP0000751_myopathy | 3.07613093 |
| 9 | MP0004215_abnormal_myocardial_fiber | 3.02843735 |
| 10 | MP0004130_abnormal_muscle_cell | 2.95204348 |
| 11 | MP0005330_cardiomyopathy | 2.90538520 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.81085432 |
| 13 | MP0003806_abnormal_nucleotide_metabolis | 2.75295835 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.70139120 |
| 15 | MP0005670_abnormal_white_adipose | 2.57476203 |
| 16 | MP0000749_muscle_degeneration | 2.33613465 |
| 17 | MP0008875_abnormal_xenobiotic_pharmacok | 2.32726080 |
| 18 | MP0003252_abnormal_bile_duct | 2.31179498 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.27643655 |
| 20 | MP0005666_abnormal_adipose_tissue | 2.26841254 |
| 21 | MP0004087_abnormal_muscle_fiber | 2.21783668 |
| 22 | MP0009840_abnormal_foam_cell | 2.18079856 |
| 23 | MP0008775_abnormal_heart_ventricle | 2.12160674 |
| 24 | MP0002972_abnormal_cardiac_muscle | 2.07937565 |
| 25 | MP0010234_abnormal_vibrissa_follicle | 2.06214202 |
| 26 | MP0006036_abnormal_mitochondrial_physio | 1.96071483 |
| 27 | MP0010630_abnormal_cardiac_muscle | 1.95346722 |
| 28 | MP0005385_cardiovascular_system_phenoty | 1.93040398 |
| 29 | MP0001544_abnormal_cardiovascular_syste | 1.93040398 |
| 30 | MP0006138_congestive_heart_failure | 1.80902890 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.80804434 |
| 32 | * MP0005332_abnormal_amino_acid | 1.77969722 |
| 33 | MP0005620_abnormal_muscle_contractility | 1.77634511 |
| 34 | MP0003303_peritoneal_inflammation | 1.77530425 |
| 35 | MP0002877_abnormal_melanocyte_morpholog | 1.76640464 |
| 36 | MP0000750_abnormal_muscle_regeneration | 1.73448538 |
| 37 | MP0003195_calcinosis | 1.71783772 |
| 38 | MP0002269_muscular_atrophy | 1.70674910 |
| 39 | MP0005083_abnormal_biliary_tract | 1.68930593 |
| 40 | MP0003137_abnormal_impulse_conducting | 1.66743963 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.65059498 |
| 42 | MP0004185_abnormal_adipocyte_glucose | 1.64444796 |
| 43 | * MP0002118_abnormal_lipid_homeostasis | 1.63076584 |
| 44 | MP0003221_abnormal_cardiomyocyte_apopto | 1.50923294 |
| 45 | MP0002106_abnormal_muscle_physiology | 1.49499069 |
| 46 | * MP0000609_abnormal_liver_physiology | 1.46378245 |
| 47 | MP0005375_adipose_tissue_phenotype | 1.45953337 |
| 48 | MP0001666_abnormal_nutrient_absorption | 1.44984199 |
| 49 | * MP0005319_abnormal_enzyme/_coenzyme | 1.44565150 |
| 50 | MP0002971_abnormal_brown_adipose | 1.43169872 |
| 51 | MP0004484_altered_response_of | 1.39419403 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.34818264 |
| 53 | MP0008260_abnormal_autophagy | 1.34068094 |
| 54 | MP0003828_pulmonary_edema | 1.33338202 |
| 55 | MP0010368_abnormal_lymphatic_system | 1.33058447 |
| 56 | MP0005409_darkened_coat_color | 1.29939470 |
| 57 | MP0000747_muscle_weakness | 1.29800274 |
| 58 | MP0002396_abnormal_hematopoietic_system | 1.24979937 |
| 59 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.20508090 |
| 60 | MP0004085_abnormal_heartbeat | 1.20242328 |
| 61 | MP0005369_muscle_phenotype | 1.18189006 |
| 62 | * MP0000759_abnormal_skeletal_muscle | 1.17882130 |
| 63 | MP0000858_altered_metastatic_potential | 1.16452080 |
| 64 | MP0002166_altered_tumor_susceptibility | 1.15700014 |
| 65 | MP0008438_abnormal_cutaneous_collagen | 1.12625141 |
| 66 | MP0005408_hypopigmentation | 1.12501229 |
| 67 | MP0005464_abnormal_platelet_physiology | 1.11584245 |
| 68 | MP0005451_abnormal_body_composition | 1.10478846 |
| 69 | MP0004264_abnormal_extraembryonic_tissu | 1.04848020 |
| 70 | * MP0009643_abnormal_urine_homeostasis | 1.04808827 |
| 71 | MP0004147_increased_porphyrin_level | 1.02445858 |
| 72 | MP0004233_abnormal_muscle_weight | 1.02430428 |
| 73 | MP0003453_abnormal_keratinocyte_physiol | 1.00447361 |
| 74 | MP0006035_abnormal_mitochondrial_morpho | 1.00431594 |
| 75 | MP0001545_abnormal_hematopoietic_system | 0.99945124 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 0.99945124 |
| 77 | * MP0002078_abnormal_glucose_homeostasis | 0.97085447 |
| 78 | MP0002332_abnormal_exercise_endurance | 0.96596536 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.95365164 |
| 80 | MP0000604_amyloidosis | 0.94772121 |
| 81 | MP0001915_intracranial_hemorrhage | 0.94126483 |
| 82 | MP0001853_heart_inflammation | 0.93229914 |
| 83 | MP0002127_abnormal_cardiovascular_syste | 0.92483769 |
| 84 | MP0005334_abnormal_fat_pad | 0.91929441 |
| 85 | MP0002796_impaired_skin_barrier | 0.91882327 |
| 86 | MP0000343_altered_response_to | 0.90843010 |
| 87 | MP0005266_abnormal_metabolism | 0.90627167 |
| 88 | MP0004957_abnormal_blastocyst_morpholog | 0.88953253 |
| 89 | MP0003566_abnormal_cell_adhesion | 0.88655155 |
| 90 | MP0000003_abnormal_adipose_tissue | 0.88123308 |
| 91 | MP0003941_abnormal_skin_development | 0.87459176 |
| 92 | MP0003950_abnormal_plasma_membrane | 0.85862612 |
| 93 | MP0005501_abnormal_skin_physiology | 0.85715838 |
| 94 | MP0004510_myositis | 0.84675236 |
| 95 | MP0004145_abnormal_muscle_electrophysio | 0.84593343 |
| 96 | MP0004019_abnormal_vitamin_homeostasis | 0.84155302 |
| 97 | MP0003567_abnormal_fetal_cardiomyocyte | 0.83721789 |
| 98 | MP0005535_abnormal_body_temperature | 0.83364450 |
| 99 | MP0010155_abnormal_intestine_physiology | 0.82832042 |
| 100 | MP0005166_decreased_susceptibility_to | 0.81692243 |
| 101 | MP0005165_increased_susceptibility_to | 0.81549826 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.80314582 |
| 103 | MP0005275_abnormal_skin_tensile | 0.79772908 |
| 104 | MP0000230_abnormal_systemic_arterial | 0.79352366 |
| 105 | MP0003279_aneurysm | 0.79164680 |
| 106 | MP0003186_abnormal_redox_activity | 0.78757011 |
| 107 | MP0004043_abnormal_pH_regulation | 0.78650490 |
| 108 | MP0009115_abnormal_fat_cell | 0.78621258 |
| 109 | MP0005076_abnormal_cell_differentiation | 0.78270433 |
| 110 | MP0002138_abnormal_hepatobiliary_system | 0.78152024 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.78134808 |
| 112 | * MP0000266_abnormal_heart_morphology | 0.78105272 |
| 113 | MP0002009_preneoplasia | 0.77947457 |
| 114 | MP0001730_embryonic_growth_arrest | 0.77895627 |
| 115 | MP0001727_abnormal_embryo_implantation | 0.77084905 |
| 116 | MP0002060_abnormal_skin_morphology | 0.76151398 |
| 117 | MP0003656_abnormal_erythrocyte_physiolo | 0.75178509 |
| 118 | MP0008007_abnormal_cellular_replicative | 0.72291145 |
| 119 | * MP0000598_abnormal_liver_morphology | 0.72137522 |
| 120 | MP0003329_amyloid_beta_deposits | 0.70578387 |
| 121 | MP0009672_abnormal_birth_weight | 0.70384517 |
| 122 | MP0002128_abnormal_blood_circulation | 0.69738355 |
| 123 | MP0002970_abnormal_white_adipose | 0.69523360 |
| 124 | MP0000013_abnormal_adipose_tissue | 0.69311585 |
| 125 | MP0001764_abnormal_homeostasis | 0.68572073 |
| 126 | MP0008961_abnormal_basal_metabolism | 0.66446954 |
| 127 | MP0009384_cardiac_valve_regurgitation | 0.63999078 |
| 128 | MP0001661_extended_life_span | 0.63910503 |
| 129 | MP0009763_increased_sensitivity_to | 0.63876279 |
| 130 | MP0001756_abnormal_urination | 0.62103311 |
| 131 | MP0004272_abnormal_basement_membrane | 0.60687294 |
| 132 | MP0003868_abnormal_feces_composition | 0.58803032 |
| 133 | MP0005448_abnormal_energy_balance | 0.58287212 |
| 134 | * MP0009642_abnormal_blood_homeostasis | 0.58029950 |
| 135 | MP0002108_abnormal_muscle_morphology | 0.56864186 |
| 136 | MP0003300_gastrointestinal_ulcer | 0.55345708 |
| 137 | MP0001879_abnormal_lymphatic_vessel | 0.55299399 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoglycemic coma (HP:0001325) | 5.00477355 |
| 2 | Ventricular tachycardia (HP:0004756) | 4.82212028 |
| 3 | * Sudden death (HP:0001699) | 4.70607540 |
| 4 | * Myoglobinuria (HP:0002913) | 4.40865290 |
| 5 | Exercise-induced myalgia (HP:0003738) | 4.30032807 |
| 6 | Right ventricular cardiomyopathy (HP:0011663) | 4.18402870 |
| 7 | Ketosis (HP:0001946) | 4.15305767 |
| 8 | Ketoacidosis (HP:0001993) | 4.13772031 |
| 9 | Hyperglycinuria (HP:0003108) | 4.09365878 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 4.02319509 |
| 11 | * Abnormality of fatty-acid metabolism (HP:0004359) | 3.96813477 |
| 12 | Dicarboxylic aciduria (HP:0003215) | 3.89768972 |
| 13 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.89768972 |
| 14 | * Hyperammonemia (HP:0001987) | 3.80298689 |
| 15 | Lipoatrophy (HP:0100578) | 3.77909173 |
| 16 | Nemaline bodies (HP:0003798) | 3.75434542 |
| 17 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.70356091 |
| 18 | Calf muscle hypertrophy (HP:0008981) | 3.68337444 |
| 19 | Atrial fibrillation (HP:0005110) | 3.67511973 |
| 20 | Abnormality of glycine metabolism (HP:0010895) | 3.65378190 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.65378190 |
| 22 | Muscle fiber splitting (HP:0003555) | 3.63578484 |
| 23 | Xanthomatosis (HP:0000991) | 3.62013192 |
| 24 | Palpitations (HP:0001962) | 3.58084523 |
| 25 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.58009834 |
| 26 | Muscle fiber inclusion bodies (HP:0100299) | 3.57972258 |
| 27 | Hyporeflexia of lower limbs (HP:0002600) | 3.57794393 |
| 28 | Deep venous thrombosis (HP:0002625) | 3.57428247 |
| 29 | * Rhabdomyolysis (HP:0003201) | 3.43077549 |
| 30 | Intrahepatic cholestasis (HP:0001406) | 3.42455357 |
| 31 | Hypoalphalipoproteinemia (HP:0003233) | 3.39781551 |
| 32 | Primary atrial arrhythmia (HP:0001692) | 3.37497562 |
| 33 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.29686399 |
| 34 | Supraventricular tachycardia (HP:0004755) | 3.24648139 |
| 35 | Asymmetric septal hypertrophy (HP:0001670) | 3.21490020 |
| 36 | Syncope (HP:0001279) | 3.20461761 |
| 37 | Supraventricular arrhythmia (HP:0005115) | 3.20407147 |
| 38 | Hepatic necrosis (HP:0002605) | 3.14906841 |
| 39 | Increased connective tissue (HP:0009025) | 3.14753643 |
| 40 | * Dilated cardiomyopathy (HP:0001644) | 3.13542563 |
| 41 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.11703749 |
| 42 | Abnormality of glycolysis (HP:0004366) | 3.11256921 |
| 43 | Atrioventricular block (HP:0001678) | 3.09875884 |
| 44 | Generalized aminoaciduria (HP:0002909) | 3.08327041 |
| 45 | Bundle branch block (HP:0011710) | 3.07628211 |
| 46 | Cholecystitis (HP:0001082) | 3.06866063 |
| 47 | Abnormal gallbladder physiology (HP:0012438) | 3.06866063 |
| 48 | Hyperglycinemia (HP:0002154) | 3.05783378 |
| 49 | Distal lower limb muscle weakness (HP:0009053) | 3.03257633 |
| 50 | Hyperlipoproteinemia (HP:0010980) | 3.03254616 |
| 51 | Subaortic stenosis (HP:0001682) | 3.01520833 |
| 52 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.01520833 |
| 53 | Abnormality of the calf musculature (HP:0001430) | 3.00257850 |
| 54 | Increased serum pyruvate (HP:0003542) | 2.96512804 |
| 55 | Hypolipoproteinemia (HP:0010981) | 2.93366336 |
| 56 | Cerebral edema (HP:0002181) | 2.90496951 |
| 57 | Heart block (HP:0012722) | 2.88572720 |
| 58 | Ventricular arrhythmia (HP:0004308) | 2.81593927 |
| 59 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.79980474 |
| 60 | Type 1 muscle fiber predominance (HP:0003803) | 2.78008091 |
| 61 | Increased muscle lipid content (HP:0009058) | 2.76271835 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.73565766 |
| 63 | Difficulty running (HP:0009046) | 2.72857909 |
| 64 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.72629680 |
| 65 | Abnormal atrioventricular conduction (HP:0005150) | 2.71935478 |
| 66 | Vertebral compression fractures (HP:0002953) | 2.66954269 |
| 67 | Metabolic acidosis (HP:0001942) | 2.66366433 |
| 68 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.63258132 |
| 69 | Polycythemia (HP:0001901) | 2.62824291 |
| 70 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.62267623 |
| 71 | Hypobetalipoproteinemia (HP:0003563) | 2.61437765 |
| 72 | Nausea (HP:0002018) | 2.59515737 |
| 73 | Complement deficiency (HP:0004431) | 2.52508416 |
| 74 | Epidermoid cyst (HP:0200040) | 2.50347405 |
| 75 | Abnormality of complement system (HP:0005339) | 2.50291895 |
| 76 | EMG: myopathic abnormalities (HP:0003458) | 2.50210371 |
| 77 | Conjunctival hamartoma (HP:0100780) | 2.49778650 |
| 78 | Prolonged QT interval (HP:0001657) | 2.49264709 |
| 79 | * Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.48135125 |
| 80 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.47019851 |
| 81 | Skin nodule (HP:0200036) | 2.46013401 |
| 82 | Lethargy (HP:0001254) | 2.45897374 |
| 83 | Prolonged partial thromboplastin time (HP:0003645) | 2.39920294 |
| 84 | Progressive muscle weakness (HP:0003323) | 2.38927532 |
| 85 | Myopathic facies (HP:0002058) | 2.37306188 |
| 86 | Proximal tubulopathy (HP:0000114) | 2.34547826 |
| 87 | Distal lower limb amyotrophy (HP:0008944) | 2.33517450 |
| 88 | Reticulocytosis (HP:0001923) | 2.32715311 |
| 89 | Hyperglycemia (HP:0003074) | 2.30201181 |
| 90 | Ragged-red muscle fibers (HP:0003200) | 2.30129564 |
| 91 | Abnormality of serum amino acid levels (HP:0003112) | 2.29229371 |
| 92 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.29063060 |
| 93 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.29063060 |
| 94 | Abnormality of glycolipid metabolism (HP:0010969) | 2.29063060 |
| 95 | Myocardial infarction (HP:0001658) | 2.27396508 |
| 96 | Increased variability in muscle fiber diameter (HP:0003557) | 2.24172555 |
| 97 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.23936413 |
| 98 | Neck muscle weakness (HP:0000467) | 2.23741624 |
| 99 | Cholelithiasis (HP:0001081) | 2.23644174 |
| 100 | Muscle stiffness (HP:0003552) | 2.22965635 |
| 101 | Ventricular fibrillation (HP:0001663) | 2.22333467 |
| 102 | Renal cortical cysts (HP:0000803) | 2.21714635 |
| 103 | Acute encephalopathy (HP:0006846) | 2.19897283 |
| 104 | Fat malabsorption (HP:0002630) | 2.18984487 |
| 105 | Hypoglycemic seizures (HP:0002173) | 2.15811267 |
| 106 | Hepatocellular necrosis (HP:0001404) | 2.15365588 |
| 107 | Vomiting (HP:0002013) | 2.15039273 |
| 108 | Hemorrhage of the eye (HP:0011885) | 2.10010051 |
| 109 | Abnormal gallbladder morphology (HP:0012437) | 2.09801759 |
| 110 | Lymphangioma (HP:0100764) | 2.05245819 |
| 111 | Hypercholesterolemia (HP:0003124) | 2.04870809 |
| 112 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.02167782 |
| 113 | Late onset (HP:0003584) | 2.01502745 |
| 114 | Abnormality of the common coagulation pathway (HP:0010990) | 2.00273032 |
| 115 | Abnormality of purine metabolism (HP:0004352) | 1.99404434 |
| 116 | Protrusio acetabuli (HP:0003179) | 1.97478820 |
| 117 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.97140994 |
| 118 | Osteolytic defects of the hand bones (HP:0009699) | 1.97104953 |
| 119 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.97104953 |
| 120 | Myotonia (HP:0002486) | 1.96962282 |
| 121 | Steatorrhea (HP:0002570) | 1.96495130 |
| 122 | Neonatal death (HP:0003811) | 1.94786665 |
| 123 | Increased intramyocellular lipid droplets (HP:0012240) | 1.93403531 |
| 124 | Gout (HP:0001997) | 1.92741511 |
| 125 | Fatigue (HP:0012378) | 1.91991546 |
| 126 | Ileus (HP:0002595) | 1.91631647 |
| 127 | Hamartoma of the eye (HP:0010568) | 1.91367120 |
| 128 | * Lactic acidosis (HP:0003128) | 1.90820697 |
| 129 | Difficulty climbing stairs (HP:0003551) | 1.90699109 |
| 130 | Hyperbilirubinemia (HP:0002904) | 1.90350707 |
| 131 | Abnormal cartilage morphology (HP:0002763) | 1.89958138 |
| 132 | Multiple enchondromatosis (HP:0005701) | 1.89943657 |
| 133 | Glomerulonephritis (HP:0000099) | 1.88616812 |
| 134 | Hydroxyprolinuria (HP:0003080) | 1.88554033 |
| 135 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.76882346 |
| 136 | Ulnar deviation of the wrist (HP:0003049) | 1.76842892 |
| 137 | Abnormality of the Achilles tendon (HP:0005109) | 1.76688880 |
| 138 | Vacuolated lymphocytes (HP:0001922) | 1.76356808 |
| 139 | Breech presentation (HP:0001623) | 1.74197429 |
| 140 | Premature rupture of membranes (HP:0001788) | 1.73888910 |
| 141 | Abnormality of the tricuspid valve (HP:0001702) | 1.73193618 |
| 142 | Flat acetabular roof (HP:0003180) | 1.71092801 |
| 143 | Foot dorsiflexor weakness (HP:0009027) | 1.70947658 |
| 144 | Abnormality of the gallbladder (HP:0005264) | 1.69996439 |
| 145 | Asymmetry of the thorax (HP:0001555) | 1.69834357 |
| 146 | Achilles tendon contracture (HP:0001771) | 1.69474606 |
| 147 | Back pain (HP:0003418) | 1.68312767 |
| 148 | Abnormality of the foot musculature (HP:0001436) | 1.66838274 |
| 149 | Abnormality of reticulocytes (HP:0004312) | 1.64211754 |
| 150 | Eczematoid dermatitis (HP:0000976) | 1.60803545 |
| 151 | Purpura (HP:0000979) | 1.60088502 |
| 152 | Abnormality of the intrinsic pathway (HP:0010989) | 1.60043629 |
| 153 | Esophageal neoplasm (HP:0100751) | 1.59507339 |
| 154 | Neoplasm of head and neck (HP:0012288) | 1.59507339 |
| 155 | Colitis (HP:0002583) | 1.59368281 |
| 156 | Esophageal varix (HP:0002040) | 1.59059868 |
| 157 | Dysostosis multiplex (HP:0000943) | 1.59013380 |
| 158 | Hypertriglyceridemia (HP:0002155) | 1.58382153 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.60316179 |
| 2 | TTN | 4.24514619 |
| 3 | TRIB3 | 4.11866875 |
| 4 | PDK3 | 3.81258741 |
| 5 | PDK4 | 3.81258741 |
| 6 | PKN2 | 3.73767162 |
| 7 | LMTK2 | 3.38318695 |
| 8 | OBSCN | 2.63664285 |
| 9 | SCYL2 | 2.48978313 |
| 10 | PHKG1 | 2.44543225 |
| 11 | PHKG2 | 2.44543225 |
| 12 | MYLK | 2.38741906 |
| 13 | PRPF4B | 2.34068233 |
| 14 | SIK1 | 2.29448996 |
| 15 | EIF2AK1 | 2.28589070 |
| 16 | PDK2 | 2.27336594 |
| 17 | ERN1 | 1.96020667 |
| 18 | TIE1 | 1.92229420 |
| 19 | NEK1 | 1.91612665 |
| 20 | NME2 | 1.89601087 |
| 21 | DMPK | 1.89052846 |
| 22 | TAOK2 | 1.85843665 |
| 23 | SMG1 | 1.80635296 |
| 24 | FGFR4 | 1.73989192 |
| 25 | PIK3CA | 1.67020916 |
| 26 | INSRR | 1.63478842 |
| 27 | IRAK3 | 1.62375111 |
| 28 | FLT3 | 1.57362506 |
| 29 | EIF2AK3 | 1.51871184 |
| 30 | RIPK1 | 1.44132456 |
| 31 | PINK1 | 1.42671428 |
| 32 | KSR2 | 1.38752664 |
| 33 | MKNK2 | 1.37739781 |
| 34 | CAMK1D | 1.32585105 |
| 35 | STK24 | 1.32530363 |
| 36 | PBK | 1.27411780 |
| 37 | JAK3 | 1.27370053 |
| 38 | CDK12 | 1.24812204 |
| 39 | MKNK1 | 1.24767653 |
| 40 | PRKAA2 | 1.18791050 |
| 41 | PTK6 | 1.18471309 |
| 42 | RPS6KB2 | 1.17621598 |
| 43 | MAP3K7 | 1.15609479 |
| 44 | MAP3K1 | 1.12586281 |
| 45 | PAK4 | 1.10734232 |
| 46 | NEK9 | 1.07135694 |
| 47 | WNK4 | 1.07023546 |
| 48 | MAP3K2 | 1.06658452 |
| 49 | PDGFRA | 1.05622148 |
| 50 | STK38L | 1.05009670 |
| 51 | MAP2K3 | 1.03958260 |
| 52 | MAP3K10 | 1.03027038 |
| 53 | LATS1 | 1.02644557 |
| 54 | PRKD1 | 0.98152019 |
| 55 | MAP3K8 | 0.98040932 |
| 56 | PRKAA1 | 0.96978427 |
| 57 | EPHB1 | 0.95504854 |
| 58 | ILK | 0.93891958 |
| 59 | ZAP70 | 0.92468579 |
| 60 | TTK | 0.91360232 |
| 61 | KDR | 0.91286576 |
| 62 | PAK3 | 0.90703176 |
| 63 | TGFBR2 | 0.89827294 |
| 64 | TAOK1 | 0.89522780 |
| 65 | MST1R | 0.88815835 |
| 66 | RIPK4 | 0.83092311 |
| 67 | MAPK11 | 0.82004894 |
| 68 | MAP3K3 | 0.81668561 |
| 69 | MAP3K14 | 0.81087450 |
| 70 | TESK2 | 0.79039484 |
| 71 | ABL2 | 0.78247593 |
| 72 | TESK1 | 0.76383872 |
| 73 | CAMK1G | 0.76362786 |
| 74 | ICK | 0.74705663 |
| 75 | PIM2 | 0.74016041 |
| 76 | STK4 | 0.72980609 |
| 77 | MAPK12 | 0.71346708 |
| 78 | CLK1 | 0.69663753 |
| 79 | PIK3CG | 0.65951849 |
| 80 | MAPKAPK3 | 0.62278529 |
| 81 | JAK1 | 0.62263586 |
| 82 | ROCK1 | 0.61726562 |
| 83 | LRRK2 | 0.60881007 |
| 84 | PDPK1 | 0.59599490 |
| 85 | MTOR | 0.57433352 |
| 86 | GRK7 | 0.56549257 |
| 87 | TYK2 | 0.55904515 |
| 88 | CAMK2D | 0.55693602 |
| 89 | MAP3K5 | 0.55641394 |
| 90 | RAF1 | 0.54612368 |
| 91 | EEF2K | 0.54403016 |
| 92 | JAK2 | 0.54264180 |
| 93 | PRKACG | 0.54049484 |
| 94 | BMPR2 | 0.53821494 |
| 95 | PAK2 | 0.53338197 |
| 96 | MAP3K6 | 0.53026049 |
| 97 | FGFR3 | 0.50906006 |
| 98 | DDR2 | 0.50855786 |
| 99 | TRPM7 | 0.50572394 |
| 100 | MUSK | 0.50238607 |
| 101 | EPHA3 | 0.50207950 |
| 102 | PDK1 | 0.49047756 |
| 103 | CAMK4 | 0.48162049 |
| 104 | MAP4K1 | 0.47888042 |
| 105 | LATS2 | 0.47747250 |
| 106 | CDC42BPA | 0.47245135 |
| 107 | TBK1 | 0.46838876 |
| 108 | MET | 0.45218903 |
| 109 | YES1 | 0.45192843 |
| 110 | STK38 | 0.43133147 |
| 111 | MAP3K12 | 0.42977744 |
| 112 | MOS | 0.42383801 |
| 113 | PTK2 | 0.42216901 |
| 114 | RET | 0.40330058 |
| 115 | DAPK3 | 0.40256226 |
| 116 | SGK3 | 0.39956335 |
| 117 | ARAF | 0.39325813 |
| 118 | CDK4 | 0.38961229 |
| 119 | ALK | 0.38250388 |
| 120 | EPHB2 | 0.37544096 |
| 121 | EPHA2 | 0.37168984 |
| 122 | STK10 | 0.37053921 |
| 123 | FRK | 0.36128009 |
| 124 | FGFR2 | 0.35739997 |
| 125 | NTRK1 | 0.35598677 |
| 126 | PKN1 | 0.34859518 |
| 127 | PRKG2 | 0.31896860 |
| 128 | RPS6KL1 | 0.30701213 |
| 129 | RPS6KC1 | 0.30701213 |
| 130 | PRKACB | 0.29882516 |
| 131 | WNK1 | 0.29037345 |
| 132 | DYRK1B | 0.28784969 |
| 133 | PRKCH | 0.28436876 |
| 134 | MAP3K11 | 0.28096991 |
| 135 | AKT2 | 0.27934439 |
| 136 | ZAK | 0.27397259 |
| 137 | ERBB4 | 0.26739605 |
| 138 | MAP2K1 | 0.26666334 |
| 139 | RPS6KA1 | 0.26638418 |
| 140 | RPS6KA6 | 0.25736446 |
| 141 | FER | 0.25192792 |
| 142 | GSK3A | 0.24457693 |
| 143 | CDK6 | 0.24347881 |
| 144 | PTK2B | 0.23479010 |
| 145 | PDGFRB | 0.22901908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.23148989 |
| 2 | * Fatty acid degradation_Homo sapiens_hsa00071 | 3.73760590 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.64075382 |
| 4 | * Propanoate metabolism_Homo sapiens_hsa00640 | 3.54058253 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.47820950 |
| 6 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.23234868 |
| 7 | * Fatty acid metabolism_Homo sapiens_hsa01212 | 2.90777085 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.89129627 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.57987466 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.56076938 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.43670702 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.42471881 |
| 13 | * Carbon metabolism_Homo sapiens_hsa01200 | 2.34030375 |
| 14 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.30303645 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.24068607 |
| 16 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.17462352 |
| 17 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.00692692 |
| 18 | * Butanoate metabolism_Homo sapiens_hsa00650 | 1.96891714 |
| 19 | Peroxisome_Homo sapiens_hsa04146 | 1.80765440 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.61728095 |
| 21 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.55206870 |
| 22 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.54489161 |
| 23 | * Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.49771123 |
| 24 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.49080702 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.45773404 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.45418311 |
| 27 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.45282376 |
| 28 | * Fatty acid elongation_Homo sapiens_hsa00062 | 1.37699280 |
| 29 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.35493191 |
| 30 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.32239135 |
| 31 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.29819478 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.28086284 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25947706 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23647487 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.21661073 |
| 36 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.19603719 |
| 37 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.18304611 |
| 38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.16538581 |
| 39 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.16199684 |
| 40 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.14327544 |
| 41 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.12513525 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.12204955 |
| 43 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.12154895 |
| 44 | Bile secretion_Homo sapiens_hsa04976 | 1.06424345 |
| 45 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.06090706 |
| 46 | * Lysine degradation_Homo sapiens_hsa00310 | 1.04157704 |
| 47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.01445876 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.99640054 |
| 49 | Parkinsons disease_Homo sapiens_hsa05012 | 0.96215438 |
| 50 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.95590336 |
| 51 | Histidine metabolism_Homo sapiens_hsa00340 | 0.95236262 |
| 52 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.93570221 |
| 53 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93268116 |
| 54 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.92885877 |
| 55 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.92713670 |
| 56 | Insulin resistance_Homo sapiens_hsa04931 | 0.92138167 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.90839616 |
| 58 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89965205 |
| 59 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.87830887 |
| 60 | Thyroid cancer_Homo sapiens_hsa05216 | 0.87216736 |
| 61 | ABC transporters_Homo sapiens_hsa02010 | 0.86859431 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86478873 |
| 63 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.85293078 |
| 64 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80244983 |
| 65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.78974419 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.78819258 |
| 67 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78222817 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 0.77842982 |
| 69 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.76080357 |
| 70 | Lysosome_Homo sapiens_hsa04142 | 0.74866698 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.72006087 |
| 72 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.71822375 |
| 73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66992821 |
| 74 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65871328 |
| 75 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.65364497 |
| 76 | Alzheimers disease_Homo sapiens_hsa05010 | 0.63071673 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.61519692 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59874115 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.59748743 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.58229822 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.54129435 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.53308775 |
| 83 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.52214627 |
| 84 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51472809 |
| 85 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.49156880 |
| 86 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44231510 |
| 87 | Huntingtons disease_Homo sapiens_hsa05016 | 0.43504567 |
| 88 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.43430069 |
| 89 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43321355 |
| 90 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.42654011 |
| 91 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42620097 |
| 92 | Mineral absorption_Homo sapiens_hsa04978 | 0.41744517 |
| 93 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.40894922 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.40867342 |
| 95 | Bladder cancer_Homo sapiens_hsa05219 | 0.39028152 |
| 96 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.36947342 |
| 97 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.36119805 |
| 98 | Asthma_Homo sapiens_hsa05310 | 0.35171860 |
| 99 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.31981704 |
| 100 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.31709820 |
| 101 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31283895 |
| 102 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.30917375 |
| 103 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.30752588 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30725536 |
| 105 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.30434049 |
| 106 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.28972738 |
| 107 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.28662255 |
| 108 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.27392507 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.27116241 |
| 110 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.26206338 |
| 111 | Pertussis_Homo sapiens_hsa05133 | 0.24368831 |
| 112 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.22568496 |
| 113 | Influenza A_Homo sapiens_hsa05164 | 0.22523820 |
| 114 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.20656977 |
| 115 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.20303231 |
| 116 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.18659911 |
| 117 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.15356094 |
| 118 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12260765 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.11657183 |
| 120 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.09920365 |
| 121 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.09134547 |
| 122 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.08568651 |
| 123 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.07471915 |
| 124 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.06683660 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.04237565 |
| 126 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.01523480 |
| 127 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.01511177 |
| 128 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.01393749 |
| 129 | Prion diseases_Homo sapiens_hsa05020 | 0.00902245 |

